<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="H2N2 and H3N3 flu, HIV, and SARS, while MERS and" exact="Ebola" post="viruses are considered still in a prepandemic phase. Hard"/>
 <result pre="and 2012), SARS (2009), while MERS (2012 to now) and" exact="Ebola" post="(1975 to now) viruses are in a prepandemic phase."/>
 <result pre="into host cells. Glycofullerenes The emerging of mortal viruses, like" exact="Ebola" post="or Zika, and the lack of suitable treatments led"/>
 <result pre="the inhibition capacity of the glycofullerenes on viral infection of" exact="Ebola" post="(Figure 6, route A). The study revealed an IC50"/>
 <result pre="between fullerene and mannose IC50 ref glycofullerene monosaccharide malonate 12" exact="Ebola" post="8 2Â Î¼M (66) glycofullerene monosaccharide trialkynyl pentaerythritol 36"/>
 <result pre="Ebola 8 2Â Î¼M (66) glycofullerene monosaccharide trialkynyl pentaerythritol 36" exact="Ebola" post="22 68Â Î¼M glycofullerene monosaccharide trialkynyl pentaerythritol 36 Ebola"/>
 <result pre="36 Ebola 22 68Â Î¼M glycofullerene monosaccharide trialkynyl pentaerythritol 36" exact="Ebola" post="28 0.3Â Î¼M trideca-fullerenesa monosaccharide malonate 120 Ebola 8"/>
 <result pre="pentaerythritol 36 Ebola 28 0.3Â Î¼M trideca-fullerenesa monosaccharide malonate 120" exact="Ebola" post="8 20.375Â nM (69) trideca-fullerenesb monosaccharide malonate 120 Ebola"/>
 <result pre="120 Ebola 8 20.375Â nM (69) trideca-fullerenesb monosaccharide malonate 120" exact="Ebola" post="8 0.667Â nM glycofullerene disaccharide trialkynyl pentaerythritol 36 Zika"/>
 <result pre="glycofullerene disaccharide trialkynyl pentaerythritol 36 Zika 29 8.35Â nM (70)" exact="Dengue" post="7.71Â nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 120 Zika 29"/>
 <result pre="nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 120 Zika 29 0.52Â nM" exact="Dengue" post="0.098Â nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 360 Zika 48"/>
 <result pre="nM trideca-fullerenes disaccharide trialkynyl pentaerythritol 360 Zika 48 0.067Â nM" exact="Dengue" post="0.035Â nM micellar glycofullerenes monosaccharide trialkynyl pentaerythritol 6 Ebola"/>
 <result pre="nM Dengue 0.035Â nM micellar glycofullerenes monosaccharide trialkynyl pentaerythritol 6" exact="Ebola" post="23 424Â nM (72) micellar glycofullerenes monosaccharide trialkynyl pentaerythritol"/>
 <result pre="23 424Â nM (72) micellar glycofullerenes monosaccharide trialkynyl pentaerythritol 12" exact="Ebola" post="25 196Â nM aSmall spacer between core C60 and"/>
 <result pre="orders of magnitude lower was measured on the inhibition of" exact="Ebola" post="virus (Table 3).66,68 In order to present more carbohydrates"/>
 <result pre="this molecule was studied in vitro with viral pseudoparticles of" exact="Dengue" post="and Zika. The comparison was made between 360 and"/>
 <result pre="results highlighted a picomolar IC50 inhibition on both Zika and" exact="Dengue" post="models for the 360 disaccharide glycofullerene (Table 3). The"/>
 <result pre="of carbohydrate at the surface, leading to an inhibition of" exact="Ebola" post="virus in the nanomolar range (IC50 of 424 nM"/>
 <result pre="broad spectrum viral blocking capacity in vitro for enveloped (e.g.," exact="Japanese encephalitis" post="virus, Dengue virus, and Zika virus) and non-enveloped viruses"/>
 <result pre="blocking capacity in vitro for enveloped (e.g., Japanese encephalitis virus," exact="Dengue" post="virus, and Zika virus) and non-enveloped viruses (e.g., porcine"/>
 <result pre="in various types of viruses (e.g., herpes viruses, human papillomavirus," exact="Dengue" post="virus).83 The use of organic sulfate-functionalized graphene sheets mimicking"/>
 <result pre="graphene nanosheets in the proximity of the surface of the" exact="Ebola" post="viral matrix protein VP40 showing that the nanosheets can"/>
 <result pre="VP40, a key protein for the replication and stability of" exact="Ebola" post="virus (Figure 8).93 These findings suggest that graphene nanosheets"/>
 <result pre="biosynthesized from Actinobacteria showing good stability and capacity to inhibit" exact="Dengue" post="virus in vitro.120 Moreover, SeNPs were used to carry"/>
 <result pre="as chronic inflammation may contribute to the aggravation of the" exact="Covid-19" post="symptoms and to the general spread of the infection.124"/>
 <result pre="10.2147/IJN.S50070. XiangD.; ChenQ.; PangL.; ZhengC.Inhibitory Effects of Silver Nanoparticles on" exact="H1N1 Influenza" post="A Virus In Vitro. J. Virol. Methods2011, 178, 137â€&quot;142."/>
 <result pre="XiangD.; ChenQ.; PangL.; ZhengC.Inhibitory Effects of Silver Nanoparticles on H1N1" exact="Influenza" post="A Virus In Vitro. J. Virol. Methods2011, 178, 137â€&quot;142."/>
 <result pre="L.; HussainS. M.A Preliminary Assessment of Silver Nanoparticle Inhibition of" exact="Monkeypox" post="Virus Plaque Formation. Nanoscale Res. Lett.2008, 3, 129â€&quot;133. 10.1007/s11671-008-9128-2."/>
 <result pre="Based Codelivery of Oseltamivir to Inhibit the Activity of the" exact="H1N1 Influenza" post="Virus through ROS-Mediated Signaling Pathways. ACS Appl. Mater. Interfaces2016,"/>
 <result pre="Codelivery of Oseltamivir to Inhibit the Activity of the H1N1" exact="Influenza" post="Virus through ROS-Mediated Signaling Pathways. ACS Appl. Mater. Interfaces2016,"/>
 <result pre="10.1021/acsami.6b06613.27588566 LiY.; LinZ.; ZhaoM.; GuoM.; XuT.; WangC.; XiaH.; ZhuB.Reversal of" exact="H1N1 Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Amantadine. RSC"/>
 <result pre="LiY.; LinZ.; ZhaoM.; GuoM.; XuT.; WangC.; XiaH.; ZhuB.Reversal of H1N1" exact="Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Amantadine. RSC"/>
 <result pre="LiY.; GuoM.; XuT.; WangC.; ZhaoM.; WangH.; ChenT.; ZhuB.The Inhibition of" exact="H1N1 Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Zanamivir. RSC"/>
 <result pre="GuoM.; XuT.; WangC.; ZhaoM.; WangH.; ChenT.; ZhuB.The Inhibition of H1N1" exact="Influenza" post="Virus-Induced Apoptosis by Silver Nanoparticles Functionalized with Zanamivir. RSC"/>
 <result pre="I.; BarclayW. S.; ZambonM. C.Changes in In Vitro Susceptibility of" exact="Influenza" post="A H3N2 Viruses to a Neuraminidase Inhibitor Drug During"/>
 <result pre="ParkG.; ParkC.; SongD.; HaamS.Porous Gold Nanoparticles for Attenuating Infectivity of" exact="Influenza" post="A Virus. J. Nanobiotechnol.2020, 18, 5410.1186/s12951-020-00611-8. HalderA.; DasS.; OjhaD.;"/>
 <result pre="WileyD. C.Receptor Binding and Membrane Fusion in Virus Entry: The" exact="Influenza" post="Hemagglutinin. Annu. Rev. Biochem.2000, 69, 531â€&quot;569. 10.1146/annurev.biochem.69.1.531.10966468 SametbandM.; ShuklaS.;"/>
 <result pre="ShuklaS.; MeningherT.; HirshS.; MendelsonE.; SaridR.; GedankenA.; MandelboimM.Effective Multi-Strain Inhibition of" exact="Influenza" post="Virus by Anionic Gold Nanoparticles. MedChemComm2011, 2, 421â€&quot;423. 10.1039/c0md00229a."/>
 <result pre="10.1002/chem.201504262.26875938 PappI.; SiebenC.; LudwigK.; RoskampM.; BÃ¶ttcherC.; SchlechtS.; HerrmannA.; HaagR.Inhibition of" exact="Influenza" post="Virus Infection by Multivalent Sialic-Acid- Functionalized Gold Nanoparticles. Small2010,"/>
 <result pre="Interfaces2019, 11, 19799â€&quot;19807. 10.1021/acsami.9b04240.31099550 NoyceJ. O.; MichelsH.; KeevilC. W.Inactivation of" exact="Influenza" post="A Virus on Copper Versus Stainless Steel Surfaces. Appl."/>
 <result pre="TaniM.; YamamotoY.; YamadaM.; NakamuraK.; ImaiK.Inactivation and Morphological Changes of Avian" exact="Influenza" post="Virus by Copper Ions. Arch. Virol.2008, 153, 1467â€&quot;1472. 10.1007/s00705-008-0154-2.18592130"/>
 <result pre="Nanosized Copper(i) Iodide Particles Showing Inactivation Activity against 2009 Pandemic" exact="H1N1 Influenza" post="Virus. Appl. Environ. Microbiol.2012, 78 (78), 951â€&quot;955. 10.1128/AEM.06284-11.22156433 HangX.;"/>
 <result pre="Copper(i) Iodide Particles Showing Inactivation Activity against 2009 Pandemic H1N1" exact="Influenza" post="Virus. Appl. Environ. Microbiol.2012, 78 (78), 951â€&quot;955. 10.1128/AEM.06284-11.22156433 HangX.;"/>
 <result pre="Globular Multivalent Glycofullerenes as Potent Inhibitors in a Model of" exact="Ebola" post="Virus Infection. Nat. Chem.2016, 8, 50â€&quot;57. 10.1038/nchem.2387.27055288 Ramos-SorianoJ.; ReinaJ."/>
 <result pre="StahelinR. V.; ChapagainP. P.Graphene-VP40 Interactions and Potential Disruption of the" exact="Ebola" post="Virus Matrix Filaments. Biochem. Biophys. Res. Commun.2017, 493, 176â€&quot;181."/>
 <result pre="Absence of Reactive Oxygen Species Improves the Resolution of Lung" exact="Influenza" post="Infection. Eur. J. Immunol.2006, 36, 1364â€&quot;1373. 10.1002/eji.200635977.16703568 TavakoliA.; Ataei-PirkoohA.;"/>
 <result pre="FarahmandM.; JavanmardD.; KianiS. J.; EsghaeiM.; Pirhajati-MahabadiV.; Ataei-PirkoohA.; MonavariS. H.Inhibition of" exact="H1N1 Influenza" post="Virus Infection by Zinc Oxide Nanoparticles: Another Emerging Application"/>
 <result pre="JavanmardD.; KianiS. J.; EsghaeiM.; Pirhajati-MahabadiV.; Ataei-PirkoohA.; MonavariS. H.Inhibition of H1N1" exact="Influenza" post="Virus Infection by Zinc Oxide Nanoparticles: Another Emerging Application"/>
 <result pre="GongG.; XiaY.; WangC.; ChenY.; HuaL.; ZhongJ.; TangY.; LiuX.; ZhuB.Restriction of" exact="H1N1 Influenza" post="Virus Infection by Selenium Nanoparticles Loaded with Ribavirin via"/>
 <result pre="XiaY.; WangC.; ChenY.; HuaL.; ZhongJ.; TangY.; LiuX.; ZhuB.Restriction of H1N1" exact="Influenza" post="Virus Infection by Selenium Nanoparticles Loaded with Ribavirin via"/>
 <result pre="LinZ.; LiY.; GuoM.; XiaoM.; WangC.; ZhaoM.; XuT.; XiaY.; ZhuB.Inhibition of" exact="H1N1 Influenza" post="Virus by Selenium Nanoparticles Loaded with Zanamivir through P38"/>
 <result pre="LiY.; GuoM.; XiaoM.; WangC.; ZhaoM.; XuT.; XiaY.; ZhuB.Inhibition of H1N1" exact="Influenza" post="Virus by Selenium Nanoparticles Loaded with Zanamivir through P38"/>
 <result pre="ChenT.; ZhuB.Inhibitory Activity of Selenium Nanoparticles Functionalized with Oseltamivir on" exact="H1N1 Influenza" post="Virus. Int. J. Nanomed.2017, 12, 5733â€&quot;5743. 10.2147/IJN.S140939. LiY.; LinZ.;"/>
 <result pre="ZhuB.Inhibitory Activity of Selenium Nanoparticles Functionalized with Oseltamivir on H1N1" exact="Influenza" post="Virus. Int. J. Nanomed.2017, 12, 5733â€&quot;5743. 10.2147/IJN.S140939. LiY.; LinZ.;"/>
 <result pre="10.2147/IJN.S140939. LiY.; LinZ.; GuoM.; ZhaoM.; XiaY.; WangC.; XuT.; ZhuB.Inhibition of" exact="H1N1 Influenza" post="Virus-Induced Apoptosis by Functionalized Selenium Nanoparticles with Amantadine through"/>
 <result pre="LiY.; LinZ.; GuoM.; ZhaoM.; XiaY.; WangC.; XuT.; ZhuB.Inhibition of H1N1" exact="Influenza" post="Virus-Induced Apoptosis by Functionalized Selenium Nanoparticles with Amantadine through"/>
 <result pre="to Gold Nanoparticles Confers Protection against H1N1, H3N2 and H5N1" exact="Influenza" post="A Viruses. Antiviral Res.2017, 141, 62â€&quot;72. 10.1016/j.antiviral.2017.01.021.28161578 SekimukaiH.; Iwata-YoshikawaN.;"/>
</results>
